|
|
|
|
|
|
|
|
|
Indevus shares double on deals with FDA, Teva
|
|
NEW YORK (AP) -- Shares of Indevus Pharmaceuticals Inc. more than doubled Friday after the company said it is collaborating with Teva Pharmaceutical Industries Ltd. to develop a treatment for stuttering and could move forward with its delayed horomonal disorder drug.
|
|
The Full Text...
|
|
|
|
|
|
|
|